Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Luciana Melo Garcia, Tzu-Fei Wang, Michael Kennah, Abdullah Alanazi, Sarah Mckeague, John Kuruvilla, Inna Gong, Naomi Marali Xiao, Christopher Lemieux, Camille Sylvestre, Amaris Balitsky, Isabelle Fleury, Mathias Castonguay, Robert Puckrin, Hannah Cherniawsky, Amani Ahmed, Mahmoud Elsawy, Maggie McGuire, Miriam Kimpton

Blood (2025) 146 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2025-4496

Published: 2025

Journal Articles

Patient journey with axicabtagene ciloleucel for relapsed or refractory large B cell lymphoma in Canada: Manufacturing experience and impact of patient location to treatment centre

Sita Bhella, Isabelle Fleury, Christopher Lemieux, Sue ZJ Li, Lieven Billen, David Myers, Marie-Pierre Fontaine, Iwona Grzegorczyk-Manuel, Brad Du, Taryn Shuler, Natasha Kekre

Blood (2025) 146 (Supplement 1): 2730.

https://doi.org/10.1182/blood-2025-2730

Published: 2025

Journal Articles

A Canadian national needs assessment for an immunology curriculum for hematology residents

Jennifer Teichman, Eric Tseng, Christopher Lemieux, Hayley Merkeley, Vicky Chan, Christine Cserti-Gazdewich, Catharine Walsh

Blood (2025) 146 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2025-2867

Published: 2025

Journal Articles

Multicenter real-world experience of belumosudil treatment in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: Clinical outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Rebeca Bailen, Keven Vachon, Brittany Salter, Christopher Lemieux, Kareem Jamani, Mohamed Elemary, Sylvie Lachance, Jonas Mattsson, Kylie Lepic, Amani Ahmed, Jennifer White, Felipe Peña-Muñoz, Juan Alberto Martín González, Jose Antonio Perez Simon, Matthias Fante, Daniel Wolff, Mi Kwon, Dennis Kim

Blood (2025) 146 (Supplement 1): 4239.

https://doi.org/10.1182/blood-2025-4239

Published: 2025

Journal Articles

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Blood (2025) 146 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2025-4284

Published: 2025

Journal Articles

Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second-line or beyond in chronic GVHD patients after steroid failure

Blood (2025) 146 (Supplement 1): 6031.

https://doi.org/10.1182/blood-2025-6031

Published: 2025

Journal Articles

Propensity score matching analysis comparing the efficacy and long-term outcomes of belumosudil to the best available treatment as a historical control, used as second-line therapy or beyond for chronic GVHD after steroid failure.

Blood (2025) 146 (Supplement 1): 6025.

https://doi.org/10.1182/blood-2025-6025

Published: 2025

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Nihar Desai, Arjun Law, Christopher Lemieux, Keven Vachon, Kareem Jamani, Mohamed Elemary, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 7353.

https://doi.org/10.1182/blood-2024-211615

Published: 2024

Journal Articles

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Yomna Eissa, Hyeoung-Joon Kim, Joon Ho Moon, Robert Zeiser, Francesca Biavasco, Christopher Lemieux, Mohamed Elemary, Varun Mehra, Mili Shah, Ahmed Alotaibi, Yu Cai, Xianmin Song, Jae-Sook Ahn, Sang Kyun Sohn, Mohsen Al Zahrani, Muhned Alhumaid, Hee-Je Kim, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 778.

https://doi.org/10.1182/blood-2024-208622

Published: 2024

Journal Articles

Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada

Kimberly Guinan, Laurie Demers-Rozon, Monika Ham, Yoann Brassard, Nancy Paul Roc, Paola Lembo, Grace Christou, Christopher Lemieux, Stephane Barakat, Yanqing Xu, Mathieu Pelletier, Jean Lachaine

Blood (2024) 144 (Supplement 1): 5057.

https://doi.org/10.1182/blood-2024-207342

Published: 2024

Journal Articles

Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Daniel Levin, Kareem Jamani, Swe Mar Linn, Benoit Yu, Arjun D. Law, Rajat Kumar, Christopher Lemieux, Mohamed Elemary, Dennis Dong Hwan Kim

Blood (2023) 142 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2023-188204

Published: 2023

Journal Articles

Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease

Alistair Murray, Swe Mar Linn, Benoit Yu, Igor Novitzky-Basso, Jonas Mattsson, Mohamed Elemary, Jennifer White, Christopher Lemieux, Kareem Jamani, Dennis Kim

Blood (2022) 140 (Supplement 1): 7662–7663.

https://doi.org/10.1182/blood-2022-164874

Published: 2022

Journal Articles

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux

Blood (2022) 140 (Supplement 1): 3304–3305.

https://doi.org/10.1182/blood-2022-170223

Published: 2022

Journal Articles

Geographical CAR-T Unmet Needs for Patients with Large B-Cell Lymphoma in the Province of Quebec

Maria Murphy, Mathilde Fromentin, Julie Campeau, Michael Sebag, Félix Couture, Jean-François Larouche, Christopher Lemieux, Silvy Lachance, Sandra Cohen, Luigina Mollica, Olivier Veilleux, Isabelle Fleury

Blood (2022) 140 (Supplement 1): 13228–13229.

https://doi.org/10.1182/blood-2022-156473

Published: 2022

Journal Articles

Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant

Christopher Lemieux, MD, Lori S. Muffly, MD MS, Sally Arai, MD MS, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Laura J. Johnston, MD, Wen-Kai Weng, MD PhD, Parveen Shiraz, MD, Matthew J. Frank, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Robert Lowsky, MD FRCP

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134250

Published: 2020

Journal Articles

Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma

Christopher Lemieux, MD, Juliana Craig, BA, David Iberri, MD, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Lori S. Muffly, MD MS, Parveen Shiraz, MD, Michaela Liedtke, MD, Andrew R. Rezvani, MD, Matthew J. Frank, MD PhD, Wen-Kai Weng, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, Robert S. Negrin, MD, David B. Miklos, MD PhD, Surbhi Sidana, MD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-137091

Published: 2020

Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD

Blood (2017) 130 (Supplement 1): 5530.

https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530

Published: 2017

Journal Articles

Evaluation of the Impact of Hematopoietic Stem Cell Transplant on the Quality of Life of Elderly Patients Treated for Lymphoma

Christopher Lemieux, MD, Nadia M. Bambace, MD, Jean Roy, MD, Sandra Cohen, MD, Imran Ahmad, MD, Lea Bernard, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MD

Blood (2016) 128 (22): 4788.

https://doi.org/10.1182/blood.V128.22.4788.4788

Published: 2016

Journal Articles

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

Christopher Lemieux, MD, Imran Ahmad, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Jean Roy, MD PhD, Silvy Lachance, MD

Blood (2015) 126 (23): 3171.

https://doi.org/10.1182/blood.V126.23.3171.3171

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Patient journey with axicabtagene ciloleucel for relapsed or refractory large B cell lymphoma in Canada: Manufacturing experience and impact of patient location to treatment centre

A Canadian national needs assessment for an immunology curriculum for hematology residents

Multicenter real-world experience of belumosudil treatment in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: Clinical outcomes and risk factor analysis for failure-free survival.

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second-line or beyond in chronic GVHD patients after steroid failure

Propensity score matching analysis comparing the efficacy and long-term outcomes of belumosudil to the best available treatment as a historical control, used as second-line therapy or beyond for chronic GVHD after steroid failure.

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada

Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

Geographical CAR-T Unmet Needs for Patients with Large B-Cell Lymphoma in the Province of Quebec

Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant

Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Evaluation of the Impact of Hematopoietic Stem Cell Transplant on the Quality of Life of Elderly Patients Treated for Lymphoma

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only